Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication – a study in ambulatory patients
Authors:
- 15 June 2017
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 83 (9) , 2107-2117
Abstract
Aims: The aim of the present study was to evaluate the impact of adverse drug events (ADEs) and treatment satisfaction on antihypertensive medication adherence.Methods: A cross‐sectional study was conducted in six public hospitals in Ethiopia. We included adult ambulatory patients on antihypertensive medication. Adherence was measured using the eight‐point Morisky Medication Adherence Scale, which categorizes as low (0–5), medium (6–7) and high (8) adherence. Treatment satisfaction was measured using the Treatment Satisfaction Questionnaire for Medication (TSQM) version 1.4, which included questions about ADEs. Data were analysed using generalized ordered logistic regression with 95% confidence intervals (CIs).Results: We included 925 out of 968 patients. Overall, 42% of patients scored low, 37% medium and 21% high adherence. Satisfaction with treatment was low, with a mean (standard deviation) TSQM score for global satisfaction of 51 (14). A total of 193 (21%) patients experienced 421 ADEs – mainly dyspeptic symptoms (12%), headache (11%) and cough (11). Experiencing more ADEs reduced the odds of being adherent [low vs. medium/high: odds ratio (OR) OR1 0.77 (95% CI 0.67, 0.89), and low/medium vs. high: OR2 0.55 (05% CI 0.41, 0.73)]. Being more satisfied increased the odds of being adherent [low vs. medium/high: OR1 1.02 (95% CI 1.01, 1.03)]. Taking medication >1 year [OR1 = 2, 0.60 (95% CI 0.43, 0.83)] and taking calcium channel blockers [OR1 = 2 0.71 (95% CI 0.54, 0.92)] decreased the odds for both low vs. medium/high and low/medium vs. high adherence.Conclusions: Only one in five patients reported perfect (high) adherence to their antihypertensive treatment regimen. Experiencing ADEs and being dissatisfied with treatment were associated with lower adherence. In addition to addressing treatment satisfaction and drug safety in first‐world countries, these should also be addressed in resource‐poor settings, within patient consultations, to enhance adherence.Keywords
Funding Information
- Netherlands Organization for International Cooperation in Higher Education (NFP‐PhD.12/ 402)
- Netherlands Organization for International Cooperation in Higher Education
This publication has 34 references indexed in Scilit:
- Hypertension awareness, treatment and control in Africa: a systematic reviewBMC Cardiovascular Disorders, 2013
- Relationship of treatment satisfaction to medication adherence: findings from a cross-sectional survey among hypertensive patients in PalestineHealth and Quality of Life Outcomes, 2013
- Relação entre a Escala de Adesão Terapêutica de oito itens de Morisky (MMAS-8) e o controle da pressão arterialArquivos Brasileiros de Cardiologia, 2012
- Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling studyBMJ, 2012
- A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistencePatient Preference and Adherence, 2012
- A Systematic Review of Adherence to Cardiovascular Medications in Resource-Limited SettingsJournal of General Internal Medicine, 2011
- Better compliance to antihypertensive medications reduces cardiovascular riskJournal Of Hypertension, 2011
- Retracted: Predictive Validity of a Medication Adherence Measure in an Outpatient SettingThe Journal of Clinical Hypertension, 2008
- Adherence to MedicationNew England Journal of Medicine, 2005
- Patient assessment of treatment satisfaction: methods and practical issuesGut, 2004